LB
34
8
EFX
32
2
TDC
75
4
CSX
51
-2
HUM
48
6
GIS
26
3
MPC
47
3
HD
47
-5
WDC
41
-2
HAS
30
2
NTAP
64
2
TGT
25
-24
MTB
63
-2
EW
37
-2
AES
39
-4
JNPR
46
3
OXY
40
3
HOG
29
-4
IFF
53
2
SWK
56
-2
LB
34
8
EFX
32
2
TDC
75
4
CSX
51
-2
HUM
48
6
GIS
26
3
MPC
47
3
HD
47
-5
WDC
41
-2
HAS
30
2
NTAP
64
2
TGT
25
-24
MTB
63
-2
EW
37
-2
AES
39
-4
JNPR
46
3
OXY
40
3
HOG
29
-4
IFF
53
2
SWK
56
-2
Financhill
Back

Cue Biopharma Vs. Arbutus Biopharma Industry Stock Comparison

Sell
16

CUE
Cue Biopharma

Last Price:
1.04
Seasonality Move:
13.31%
Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.46
Seasonality Move:
15.21%
Sell
16
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight selling pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 39.31 Sell
Chaikin Money Flow: -136595 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.28 - 1.76) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.99 Sell
Chaikin Money Flow: -417405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.64 - 4.06) Sell
Bollinger Bands (100): (3.55 - 4.13) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.38 Sell
20-day SMA: 1.54 Sell
50-day SMA: 1.16 Sell
200-day SMA: 1.39 Sell
8-day EMA: 1.3 Sell
20-day EMA: 1.41 Sell
50-day EMA: 1.26 Sell
200-day EMA: 1.46 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.59 Sell
20-day SMA: 3.79 Sell
50-day SMA: 3.93 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.59 Sell
20-day EMA: 3.73 Sell
50-day EMA: 3.83 Sell
200-day EMA: 3.43 Buy

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):